Made Scientific, a U.S.-based contract development and manufacturing organization (CDMO) specializing in cell therapies, ...

This review examines how CAR-T cell therapy is expanding beyond blood cancers into solid tumors, autoimmune diseases, chronic ...

Pluri (PLUR), an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) ...

Add Yahoo as a preferred source to see more of our stories on Google. Cell therapies have gained steam in oncology since Novartis’s Kymriah (tisagenlecleucel) became the first chimeric antigen ...

EUDA Health Holdings Limited (NASDAQ: EUDA) ('EUDA” or the 'Company”), a Singapore-based non-invasive healthcare provider in ...

TOKYO--(BUSINESS WIRE)-- AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.’s Yokohama Technical ...

Nik Ekman is the application development manager for Cell & Gene Therapy covering the Americas at CPC. Ekman has 10 years of experience in applications engineering and process development within the ...

With iPSCs continuing to emerge as an important source of starting materials for cell therapy developers, it is crucial to tackle key remaining challenges relating to cell culture scalability and ...

Cell and gene therapies are currently niche products, even within specialty pharmacy, drugs that, by most definitions, are ...

While advances in cell & gene therapy continue to show promise for creating new treatments, this sector of the industry still ...

Cerebral Palsy Center reports Kidswell Bio is advancing stem cell therapy for cerebral palsy in the U.S., focusing on cells ...